CATEGORIES: Featured | Newly Diagnosed
SAM 2023

CMT Awareness Month 2023 Hope. Courage. Action.

by | Aug 30, 2023 | 0 comments

CMT Awareness Month 2023

Hope. Courage. Action.

This year, HNF is spotlighting 3 Key Pillars vital to CMT Awareness & Research success.

We invite you to choose from each pillar throughout this September to drive Impact That Matters!

       1. Hope

  1. Action 
  • Book a CMT Genie call to learn more about genetic testing options for CMT.
  • Share CMT Awareness with HNF’s FB profile photo frame.
  • Co-Host a CMT Presents event at your company or organization.
  1. Courage

Learn more on this topic

Related Blog Posts

Scientific Advisory Board Meeting

Scientific Advisory Board Meeting

On the 7th of November we convened our scientific advisory board meeting at the HNF offices in NY. We have written a detailed review that has been published and captures all of the discussion and make this freely available to the scientific community.

Pharnext Announces Pleotherapy Proof of Concept in Charcot-Marie-Tooth Disease Type 1A

Pharnext Announces Pleotherapy Proof of Concept in Charcot-Marie-Tooth Disease Type 1A

PARIS, December 18th, 2014 – Pharnext SAS today announced the proof of concept of its pleotherapy research and development approach based on a proprietary network pharmacology platform that identifies synergic combinations of drugs already approved for other diseases. Indeed, Pharnext’s lead pleodrug, PXT-3003, has shown positive results both in preclinical and Phase 2 clinical studies published today in the Orphanet Journal of Rare Diseases.

Join the conversation

Leave a Comment

0 Comments

Submit a Comment

Your email address will not be published. Required fields are marked *

Newsletter

Join for notifications on events, campaigns, & news